Drug Delivery Systems
Abstract
Full Text:
PDFReferences
Agnihotri S.A., Mallikarjuna N.N., Aminabhavi T.M., “Recent advances on chitosan-based micro- and nanoparticles in drug delivery”, J Control Release. 2004; 100: 5–28p.
Sood A. and Panchagnula R., “Peroral Route: An Opportunity for Protein and Peptide Drug Delivery”, Chem Rev. 2000; 101: 3275–303p.
Niculescu-Duvaz I., Springer C.J., “Andibody-directed enzyme prodrug therapy (ADEPT): a review”, Adv Drug Deliv Rev. 1997; 26: 151–72p.
Manabe T., Okino H., Maeyama R., Mizumoto K., Nagai E., Tanaka M., Matsuda T., “Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans-tissue, sustained local drug-delivery systems”, J Control Release. 2004; 100: 317–30p.
Byrne M. E., Park K., Peppas N., “Molecular imprinting within hydrogels”, Adv Drug Deliv Rev. 2002; 54: 149–61p.
Vandermeulen G. W. M., Klok H-A., “Peptide/protein hybrid material: enhanced control of structure and improved performance through conjugation of biological and synthetic polymers”, Macromol Biosci. 2003; 4: 383–98p.
DOI: https://doi.org/10.37628/jibb.v2i2.119
Refbacks
- There are currently no refbacks.